Autres articles Novembre 2006

Francesca Bursi, Susan A. Weston, Margaret M. Redfield et coll. Systolic and Diastolic Heart Failure in the Community. JAMA 2006 ; 296 : 2209-2216. 

Mihai Gheorghiade, William T. Abraham, Nancy M. Albert et coll. Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure. JAMA 2006 ; 296 : 2217-2226.

Bradley J. Willcox, Qimei He, Randi Chen et coll. Midlife Risk Factors and Healthy Survival in Men. JAMA 2006 ; 296 : 2343-2350.

Joshua I. Barzilay, Barry R. Davis, Jeffrey A. Cutler et coll. Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006 ; 166 : 2191-2201.

Lizzy M. Brewster, Gideon Mairuhu, Navin R. Bindraban et coll. Creatine Kinase Activity Is Associated With Blood Pressure. Circulation 2006 ; 114 : 2034-2039.

Walter P. Abhayaratna, Marion E. Barnes, Michael F. O’Rourke et coll. Relation of Arterial Stiffness to Left Ventricular Diastolic Function and Cardiovascular Risk Prediction in Patients ≥65 Years of Age. Am J Cardiol 2006 ; 98 : 1387-1392.

Glen L. Xiong, Brenda L. Plassman, Michael J. Helms et coll. Vascular risk factors and cognitive decline among elderly male twins. Neurology 2006 ; 67 : 1586-1591.

Sanjat Kanjilal, Edward W. Gregg, Yiling J. Cheng et coll. Socioeconomic Status and Trends in Disparities in 4 Major Risk Factors for Cardiovascular Disease Among US Adults, 1971-2002. Arch Intern Med 2006 ;  166 : 2348-2355.

Mikolaj Winnicki, Elisa Bonso, Francesca Dorigatti et coll. Effect of Body Weight Loss on Blood Pressure After 6 Years of Follow-Up in Stage 1 Hypertension. Am J Hypertens 2006 ; 19 : 1103-1109.

Benedict Martina, Alain Nordmann, Thomas Dieterle et coll. Impact of Baseline Echocardiography on Treatment Outcome in Primary Care Patients With Newly Detected Arterial Hypertension: A Randomized Trial. Am J Hypertens 2006 ; 19 : 1150-55.

Burnier M. Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy. Am J Hypertens 2006 ;19 : 1190-1196.

van den Born BJ, Koopmans RP, Groeneveld JO, van Montfrans GA. Ethnic disparities in the incidence, presentation and complications of malignant hypertension. J Hypertens. 2006 ; 24 : 2299-304.

Koshi Nakamura, Tomonori Okamura, Hideyuki Kanda et coll. Medical costs of patients with hypertension and/or diabetes: a 10-year follow-up study of National Health Insurance in Shiga, Japan. J Hypertens 2006 ; 24 : 2305-2309.

Anton H van den Meiracker, Rini GA Baggen, Sacha Pauli et coll. Spironolactone in type 2 diabetic nephropathy: effects on proteinuria, blood pressure and renal function. J Hypertens 2006 ; 24 : 2285-2292..

Pascual JM, Rodilla E, Miralles A et coll.  Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens 2006 ; 24 : 2277-84.

Alberto Zanchetti, Stevo Julius, Sverre Kjeldsen et coll. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial. J Hypertens 2006 ; 24 : 2163-2168.

Eric A. Macklin, Peter M. Wayne, Leslie A. Kalish et coll. Stop Hypertension With the Acupuncture Research Program (SHARP): Results of a Randomized, Controlled Clinical Trial. Hypertension 2006 ; 48 : 838-845.

Jun Ma, Ky-Van Lee et Randall S. Stafford. Changes in Antihypertensive Prescribing During US Outpatient Visits for Uncomplicated Hypertension Between 1993 and 2004. Hypertension 2006 ; 48 : 846-852.

Feng J. He et Graham A. MacGregor. Importance of Salt in Determining Blood Pressure in Children: Meta-Analysis of Controlled Trials. Hypertension 2006 ; 48 : 861-869.

Figueroa XF, Isakson BE, Duling BR. Vascular gap junctions in hypertension. Hypertension 2006 ; 48 : 804-11.

Ryusuke Inoue, Takayoshi Ohkubo, Masahiro Kikuya et coll. Predicting Stroke Using 4 Ambulatory Blood Pressure Monitoring-Derived Blood Pressure Indices: The Ohasama Study. Hypertension 2006 ; 48 : 877-882.

Sanjay Rajagopalan, Mbabazi Kariisa, Santo Dellegrottaglie et coll. Angiotensin Receptor Blockade Improves Vascular Compliance in Healthy Normotensive Elderly Individuals: Results From a Randomized Double-Blind Placebo-Controlled Trial. J Clin Hypertens 2006 ;  8 : 783-790.

Adeoye O, Jauch EC. Management of arterial hypertension in patients with acute stroke. Curr Treat Options Neurol 2006 ; 8 : 477-85.

Agarwal R, Andersen MJ. Blood Pressure Recordings within and outside the Clinic and Cardiovascular Events in Chronic Kidney Disease. Am J Nephrol 2006 ; 26 : 503-510

Norris K, Bourgoigne J, Gassman J et coll. ; AASK Study Group.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis 2006 ; 48 : 739-51.

Barrios V, Escobar C, Navarro A et coll. ; LAURA Investigators. Lercanidipine is an effective and well tolerated antihypertensive drug regardless the cardiovascular risk profile: The LAURA study. Int J Clin Pract 2006 ; 60 : 1364-70.

Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006 ; 7 : 829-40.

Crowley SD, Gurley SB, Herrera MJ et coll. Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006 ; 103 : 17985-90.

Rozenfeld Y, Hunt JS. Effect of patient withdrawal on a study evaluating pharmacist management of hypertension. Pharmacotherapy. 2006 ; 26 : 1565-71.

Ruixing Y, Jiaqiang D, Dezhai Y et coll.  Effects of Demographic Characteristics, Health-Related Behaviors and Lifestyle Factors on the Prevalence of Hypertension for the Middle-Aged and Elderly in the Guangxi Hei Yi Zhuang and Han Populations. Kidney Blood Press Res 2006 ; 29 : 312-320

Ruster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 2006 ; 17 : 2985-91.

Grandi AM, Laurita E, Solbiati F et coll. Angiotensin-converting Enzyme Inhibitors Influence Left Ventricular Mass and Function Independently of the Antihypertensive Effect. J Cardiovasc Pharmacol 2006 ; 48 : 207-11.

Bradley HA, Wiysonge CS, Volmink JA et coll. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 2006 ; 24 : 2131-41 (revue)

Robert A. Phillips. New-Onset Diabetes Mellitus Less Deadly Than Elevated Blood Pressure?: Following the Evidence in the Administration of Thiazide Diuretics. Arch Intern Med 2006 ; 166 : 2174-2176 (éditorial).